Visa Information

All international delegates attending the 18th Asia Oceania Congress of Nuclear Medicine and Biology (AOCNMB) & 3rd SSNMMI International Conference, taking place in Jeddah, Saudi Arabia, from 4–6 December 2026, may require a visa to enter the Kingdom of Saudi Arabia.

This applies to all categories of international delegates, including invited speakers, presenters, registered participants, exhibitors, and general attendees.

Participants are advised to check their visa eligibility and complete the appropriate application process well in advance of the Congress.

KSA Visa Platform

The official KSA Visa platform allows international visitors to explore the available visa options and review the relevant eligibility requirements, application procedures, and applicable fees.

Participants can use the platform to identify the appropriate visa option based on their nationality, passport type, country of residence, and purpose of travel.

Explore Visa Options on KSA Visa

Saudi Tourist eVisa

Travelers from eligible countries may apply online for a Saudi tourist eVisa through the official Visit Saudi eVisa Portal.

The online application generally requires:

  • A valid passport

  • A recent personal photograph

  • Personal and travel information

  • Online payment of the applicable visa fees
    Apply for a Saudi eVisa

Important Information

Visa eligibility, requirements, fees, and processing times may vary depending on the applicant’s nationality, passport type, country of residence, and selected visa category.

All international speakers, presenters, participants, exhibitors, and attendees are strongly advised to review the official requirements and submit their visa applications well in advance of the Congress before confirming their travel arrangements.

Congress registration or participation does not guarantee visa approval. All visa applications are subject to review and approval by the relevant Saudi authorities

Submit Your Abstract
Download Template
Academic Submissions Open

Submit Your Radionuclide Research

Present your peer-reviewed molecular imaging data and targeted radionuclide therapy research at the premier global symposium bridging clinical oncology and radiopharmacy.

Submission Method

The Peer-Review Process

01
02
03

Verify Formatting

Select Category

Upload Manuscript

Ensure your manuscript adheres to the official template and includes complete dosimetry metrics.

Categorize your abstract under targeted radionuclide therapies or clinical molecular diagnostics.

Submit your finalized PDF document via the secure portal before the absolute deadline.

Evaluation Criteria
Critical Date

Rigorous Peer Review

Oct 15

Submission Deadline

All submitted abstracts undergo a strict double-blind peer-review process managed by our international scientific committee. Accepted papers will be published in the official congress proceedings and indexed accordingly.

Late submissions will automatically be deferred to the following cycle.

Authors of highly-rated abstracts will be invited to deliver oral presentations during the plenary sessions.

Academic Portal

Begin Submission

Provide your academic credentials and upload your abstract file. Ensure all co-authors are listed.